Genmab — Oktober 2020

[Solsen]

Har valgt at reducere lidt på GS analysen, der har holdt hånden under Genmab. Det ligner en blodig dag med lockdowns trusler og smittetal der skræmmer.

[Solsen]

Men håber at Genmab stiger

[SEACOP]

Peak March 2021. https://financhill.com/stock-forecast/GMAB-stock-prediction

[E_L]

Novartis (NVS) CEO, Vas Narasimham on Q3 2020 Results - Earnings Call Transcript https://seekingalpha.com/article/4381882-novartis-nvs-ceo-vas-narasimham-on-q3-2020-results-earnings-call-transcript?part=single

[Bulder]

Nice: "If you look at some of the estimates on what the B-cell market could look like over the next 10 years, there are some estimates that point us to 35% to 40% of the market."

[Solsen]

Thats a lot

[Bulder]

Lad os antage at det svarer til 4 mia $. 10% heraf er 400 mio $.

[E_L]

PRAC agenda: 5.3.4. Carfilzomib - KYPROLIS (CAP) - EMEA/H/C/003790/II/0045, Orphan
Applicant: Amgen Europe B.V.

Scope: Extension of existing indication to include combination of Kyprolis (carfilzomib) with
daratumumab and dexamethasone. As a consequence, sections 4.1, 4.2, 4.8 and 5.1 of the
SmPC are updated. The package leaflet is updated in accordance
Action: For adoption of PRAC RMP AR, PRAC RMP assessment overview and advice to CHMP

[Bulder]

Professor ærgrer sig over Medicinrådets afvisning af Dar MPV https://haematologisktidsskrift.dk/2-uncategorised/768-professor-aergrer-sig-over-medicinradets-afvisning-af-dar-mpv.html

[Helge_LarsenPI-redaktør]

Ses vi kl. 17? https://event.webinarjam.com/register/8/rp8nvfw

[Bulder]

Belamaf på dansk https://haematologisktidsskrift.dk/sygdomme/myeloma/761-fda-haster-myelomatose-middel-ud-pa-markedet.html

[Klarussen]

Køber i 2050,- vi er der snart

[E_L]

New trial - A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies https://www.clinicaltrials.gov/ct2/show/NCT04606381?term=rHuPH20&lupd_s=10%2F27%2F2020&draw=2&rank=1

[E_L]

exactly 100 dkk high -> low . #UselessFacts

[GeorgeBest]

https://twitter.com/wattwurm73/status/1321464818776375296?s=21 HALOs teknologi anvendes også til Amivantamab sc!

[gentogen]

Regarding the new Amivantamab: Eligible tumor types include non-small cell lung cancer (NSCLC), squamous cell carcinoma of the head and neck (SCCHN), hepatocellular cancer (HCC), colorectal cancer (CRC), renal cell cancer (RCC), medullary thyroid cancer (MTC), gastroesophageal cancer (GEC), mesothelioma, breast cancer (BC) and ovarian cancer (OC).

[peter12]

Det lyder forkert. Hvor står det ?

[peter12]

Ok tak, jeg var ikke klar over at alle de tumor typer udtrykte EGFR og cMet. Interessant

[gentogen]

High expression of c-Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma

[gentogen]

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769407/